REQUEST FOR SUPPORT 5 TH CENTRAL AND EASTERN EUROPEAN MEETING ON VIRAL HEPATITIS AND HIV BUDAPEST, HUNGARY OCTOBER 2019 (TBC)

Size: px

Start display at page:

Download "REQUEST FOR SUPPORT 5 TH CENTRAL AND EASTERN EUROPEAN MEETING ON VIRAL HEPATITIS AND HIV BUDAPEST, HUNGARY OCTOBER 2019 (TBC)"

Arlene Townsend
5 years ago
Views:

1 5 TH CENTRAL AND EASTERN EUROPEAN MEETING ON VIRAL HEPATITIS AND HIV BUDAPEST, HUNGARY OCTOBER 2019 (TBC) REQUEST FOR SUPPORT

2 OVERVIEW INTRODUCTION The main objective of the Central and European (CEE) Meeting on Viral Hepatitis and HIV is to provide guidance to the Central/ Eastern European healthcare community regarding best practices for treating viral hepatitis and HIV and for stimulating research collaborations in this region. FACTS AND FIGURES >200 participants High involvement of local experts UNIQUE MEETING FEATURES: The CEE Meeting is developed by regional and international experts for the medical and scientific community in Eastern and Central European countries... aims to provide a unique and much needed platform for scientific and medical exchange and education on treatment of Viral Hepatitis and Coinfection with HIV... is a focused meeting that addresses regional challenges and is designed to build collaborations in order to advance the field >30 countries 61% clinicians AREA OF EXPERTISE 9% Other PROFESSIONAL ROLE 5% Other 1% Community advocate 11% Medical student 21% Hepatitis 39% ID in general 22% Researcher 61% Clinician 17% HIV 14% Hepatology 2

3 COMMITTEES WORLD S LEADING EXPERTS The CEE Meeting on Viral Hepatitis and HIV proudly collaborates with a large number of international and local experts in the field. By working together with our extensive global network of experts from various backgrounds in the field we can ensure that we will design and deliver the most relevant and state-of-the-art program. ORGANIZING COMMITTEE The members of the Organizing Committee (OC) are carefully selected experts and inspirational leaders in their respective fields. They come together on a frequent basis to develop the scientific program tailored to the needs of Healthcare professionals in the field. Furthermore, they identify clinical studies and research projects within their organizations/ network and review and select abstracts. They actively participate as session chairs and join the Q&A sessions, discussions and debates during the meeting. Mojca Maticic University Medical Centre, Ljubljana, Slovenia Jürgen Rockstroh MD University of Bonn, Germany Jonathan Schapiro MD Sheba Medical Center, Tel Aviv, Israel Saulius Caplinskas Lithuanian Centre for Communicable Diseases and AIDS, Vilnius, Lithuania Charles Boucher Erasmus Medical Centre, Rotterdam, the Netherlands Andrzej Horban Hospital for Infectious Diseases, Warsaw, Poland Pavel Khaykin MD MainFachArzt, Frankfurt, Germany Ludmila Maistat Medicines Patent Pool, Geneva, Switzerland Vadim Rassokhin MD First St. Petersburg State Medical University named Acad IP Pavlov, Russia Adrian Streinu Cercel Nat. Institute for Inf. Diseases Prof. Dr. Matei Bals, Bucharest, Romania Miłosz Parczewski Pomeranian Medical University, Szczecin, Poland Cihan Yurdaydin MD University of Ankara Medical School, Turkey 3

4 COMMITTEES SCIENTIFIC COMMITTEE The members of the Scientific Committee (SC) are hand-picked by the OC and the conference secretariat based on their significant contributions and commitment to the field. They assist the OC by providing them with topic and speaker suggestions. In addition, members of the SC participate in reviewing submitted abstracts, and play an active role during the workshop. Svitlana Antonyak, MD - Academy of Medical Sciences, Ukraine Marine Gogia, MD - Georgian Harm Reduction Network, Georgia Brygida Knysz, - Medical University of Wroclaw, Poland Cristina Popescu, - Carol Davila University of Medicine and Pharmacy, Romania Dalibor Sedlácek, - University Hospital Plzen, Czech Republic Tengiz Tsertsvadze, - I. Javakhishvili Tbilisi State University, Infectious Diseases, AIDS and Clinical Immunology Research Center, Georgia Alicja Wiercinska Drapało, - Medical University of Warsaw, Poland 4 5th CEE MEETING PROSPECTUS

NEEDS ASSESSMENT NEEDS ASSESSMENT Looking back over the last few years, we have witnessed the field of viral hepatitis and HIV undergoing major changes.

5 NEEDS ASSESSMENT NEEDS ASSESSMENT Looking back over the last few years, we have witnessed the field of viral hepatitis and HIV undergoing major changes. Therapeutic options are increasing and new data is becoming available incessantly, which makes it challenging for healthcare professionals to stay informed and provide the best treatment possible for their patients. The large variation in regional and local conditions also has a major impact on the decision-making process of the clinician. In Central/Eastern Europe, not all new treatment options are accessible, and knowledge and experience with new drug options are limited. Unfortunately, limited financial resources make regional research collaborations more challenging. In view of this complex situation, there is a need for an independent program for healthcare professionals in Central/Eastern Europe where the latest findings are translated into daily clinical practice by local and international experts, and research collaborations are fostered. The Central and Eastern European Meeting on Viral Hepatitis and HIV is an independent program, initiated in It was developed by regional and international experts to address an important unmet need of the medical and scientific community in Eastern and Central European countries. Advances in the treatment of viral hepatitis and HIV are continuing at an unprecedented rapid pace. Key challenges in the treatment of HBV and HCV as well as HIV are specific for this region and need to be discussed among clinicians and scientists within the context of this region s needs. Meeting objectives The objectives of this meeting are to: Educate the practicing clinician on the best treatment options for viral hepatitis & co-infection with HIV Share state-of-the-art information and how it relates to daily clinical practice Provide a Central/Eastern European platform for interaction and dialogue Stimulate discussion among different disciplines Build collaborations and developing research activities TARGET AUDIENCE Healthcare professionals involved in daily care of HIV and / or viral hepatitis-infected individuals, such as: Infectious disease doctors Gastro-enterologists Hepatologists Other related disciplines ESTIMATED NUMBER OF PATICIPANTS TARGET REGION Central and Eastern Europe Learning objectives After attending this program, participants will be able to: Summarize the basic concepts of viral hepatitis and HIV Describe the spread of viral hepatitis and HIV in Central/Eastern Europe Be updated on the latest developments in treatment strategies for hepatitis mono- and HIV co-infected patients Summarize the specific treatment challenges in Central/Eastern Europe Identify and adjust treatment strategies in different patient populations Discussthe advantages and possibilities of new antivirals in HCV and HIV therapy 5

6 PROGRAM PROGRAM DESCRIPTION The meeting will have a two-day program consisting of invited lectures, roundtable discussions, abstract-driven presentations and poster sessions.in order to ascertain an interactive workshop setting, much time was allocated to discussions. TOPICS FROM PREVIOUS MEETINGS - Epidemiology of HIV and Hepatitis infection in Europe - Current and new treatment strategies for HIV and Hepatitis - Diagnostics - PrEP - Country models: what has worked and what not - HIV and women s health - Switching antiretroviral therapy - Hepatitis B Cure - Clinical case discussions - IV drug use and what it means for the HIV and Hepatitis epidemic FORMAT The meeting is abstract driven. It is known as an excellent platform for young investigators to present their research. To ensure the quality of accepted abstracts, all submitted abstracts go through a blind, peer-reviewed process conducted by the members of the Organizing and Scientific Committees. 6

7 ENDURING MATERIALS INFECTIOUS DISEASES ONLINE Enduring information presented at the conference will be freely accessible and widely disseminated to reach thousands of virtual participants beyond the walls of the conference center. Infectious Diseases Online is a premier online platform offering scientific materials in special topical areas and proceedings of conferences. All the content on Infectious Diseases Online is organized by workshop and date, making it easy to find. Visitors of the website will have full access to: Abstract Books Meeting Reports Workshop Presentations Webcasts 7

8 ASSESSMENT LEARNING ASSESSMENT METHOD To assess the meeting, Virology Education provides each delegate with a detailed feedback form to assess the speakers, whether or not the meeting objectives were met, their intent to change, the rationale behind their motivation to attend, the general logistics of the meeting, and more. All the questions are then fully analyzed and a comprehensive report is created and shared with the committee members. These reports help us to better understand our delegates needs and how to improve the meeting in the future. Accreditation We aim to submit an application to the EACCME for CME accreditation of this event. For a maximum response rate, we invite the chairs of each session to encourage the participants to take a few minutes and complete the feedback forms. We are also introducing a web-based application to allow participants access to the feedback forms electronically. Conference participation grants The conference participation grants (CPG) provide healthcare professionals with the opportunity to attend a conference they would otherwise be unable to attend due to financial restrictions. All applications include a CV, a motivation letter, and potentially an abstract (requirements vary depending on the workshop). These are submitted via an independent CPG portal and are evaluated against the assessment criteria using a robust, impartial and independent peer review process. This process will ensure that only he most qualified candidates will receive CPGs. The grants are supported by the financial contributions allocated by the sponsor, who has no control, influence, or involvement in the selection process of the CPG candidates whatsoever. Priority is given to applicants who have actively participated in original research or scientific work that is being presented at the meeting and/or those who will profit most from participating in order to improve their daily clinical management. These grants help defray costs for registration, travel and accommodation for delegates and foster their ability to form valuable professional networks and develop vital collaborations. Conference participation grant applications will be solicited, selected and awarded by an expert Grant Review Committee. Please note that the TITANIUM, PLATINUM and GOLD support levels will reduce the costs for conference participation grants. 8

9 ACKNOWLEDGEMENTS MEETING PARTNERS THIS MEETING HAS PREVIOUSLY BEEN SPONSORED BY 9

10 SPONSORSHIP SPONSOR BENEFITS As a sponsor of the CEE meeting, you will have the unique opportunity to connect with clinicians and researchers from academia, research institutes and governments. You will be able to engage with potential collaborators and experts and discuss the latest advancements and information in the field of hepatitis and co-infection with HIV. Sponsoring this program will give you the following benefits: Visibility Prominent placement of your logo on conference materials (online and offline) Pre-event marketing and branding through: - Banners posted on the homepage of the website - Traffic generation to your website via the conference website - Your logo placed on monthly newsletters which are delivered to thousands of opt-in subscribers - Electronic advertising posted on several calendars linked to the event website Contribution to the program A chance to organize satellite symposia Participate in discussions Commercial benefits Exhibition opportunities Promotion option to display marketing materials such as pamphlets, flyers, postcards and other materials on the marketing table (subject to approval) Privileges Your contribution entitles you to the following privileges: Exhibition space Symposia inclusion Complimentary registrations to the event to increase your networking opportunities Other benefits described under various sponsorship levels 10

11 ABOUT US VIROLOGY EDUCATION With over 20 years of experience, Virology Education is a leading provider of innovative scientific and educational programs worldwide. Our programs provide excellent platforms for scientific exchange, education and knowledge-sharing tailored to the needs of healthcare professionals in the fields of infectious diseases, pharmacology, liver disease, and more. Our activities include the initiation and organization of real-time and online platforms for international exchange, knowledge-sharing and education for medical professionals. We have developed long-standing collaborations with world-leading experts and work together with other important stakeholders to achieve the greatest impact for our programs and to provide top quality scientific content. Our programs range from international abstract-driven workshops to small and large scale educational series, masterclasses, advisory boards, expert rounds, satellite symposia, and more. Biltstraat BJ Utrecht The Netherlands info@virology-education.com Goda Adomonis, MA Project manager goda@vironet.com More than 50 programs are planned for 2018 in more than 30 different cities around the globe! Wilco Keulen, PhD Senior Scientist wilco@vironet.com OUR IMPACT IN programs 4,187 participants 2,277 accepted abstracts 59% returning participants 28,000+ opt in subscribers

INTERNATIONAL MASTERCLASS ON LIVER DISEASE IN HIV VILNIUS, LITHUANIA 18 SEPTEMBER 2019 (TBC) REQUEST FOR SUPPORT.

INTERNATIONAL MASTERCLASS ON LIVER DISEASE IN HIV VILNIUS, LITHUANIA 18 SEPTEMBER 2019 (TBC) REQUEST FOR SUPPORT INTRODUCTION Liver disease in the setting of HIV is increasingly presenting a major concern